Dr. Saskia Neubacher

CEO & Co-Founder

Saskia is a chemist. After her chemistry studies at the Free University Berlin, she continued with her PhD in chemical biology at the Humboldt University in Berlin. She then became associate editor for chemistry journals at Wiley-VCH. In 2016, Saskia joined Tom’s group as project leader at the VU University Amsterdam and continued research on INCYPRO. She launched Incircular in 2021.

Prof. Tom Grossmann

Scientific Advisor & Co-founder

Tom is a chemist. He received his PhD in chemistry from the Humboldt University in Berlin, Germany. After post-doctoral research at Harvard University, Tom started his independent career at the Max Planck Institute and the Chemical Genomics Center in Dortmund. Since 2016, Tom is full professor and Chair of Biomimetic Chemistry at the VU University Amsterdam.

Dr. Sven Hennig

Scientific Advisor & Co-Founder

Sven is a biochemist and crystallographer. He received his PhD from the Max-Planck Institue for Molecular Physiology. After post-doctoral research at the Harry Perkins Institute for Medical Research in Perth, Sven started his own research group in 2012 at the Chemical Genomics Centre of the Max-Planck Society. He joined the VU University Amsterdam in 2017 as head of crystallography and assistant professor for structural chemical biology.

Antrea Kyriakidou

Business Development Manager

Antrea is a business developer. She holds a Master’s degree in Bio-pharmaceutical Sciences and Business Studies from Leiden University and a Bachelor’s degree in Biomedical Sciences from the University of Surrey. She started her career as a laboratory technician and later on as a laboratory manager in diagnostic laboratories, and soon after the completion of her Master’s degree, she gained experience in regulatory affairs and business development. Antrea joined the Incircular team in 2024.

Dr. Martin Bakker

Business Development Advisor

Martin Bakker is business development advisor. In the past, he worked for several companies in Management & Director roles in business development and marketing in the pharmaceutical industry. Some of the companies include OctoPlus, Dr. Reddy’s, Northern Lipids (now Evonik), and PRA Healthcare (now ICON).

Home

Technology

Pipeline

Services

About

News

Contact

About Incircular

Incircular develops stabilized protein therapeutics using a proprietary structure-guided approach. Founded in 2021 as a spin-out from VU University Amsterdam, the company builds on original research in in situ protein cyclization to address the limitations of conventional biologics.

;

Our team

Incircular is led by a multidisciplinary team combining expertise in chemistry, structural biology, and business development. Together with experienced molecular biologists and biotech specialists, the team has more than 50 years of combined experience across startups, scale-ups, and therapeutic development.

Saskia Neubacher

CEO & Co-Founder

Tom Grossman

Scientific Advisor & Co-Founder

Sven Hennig

Scientific Advisor & Co-Founder

Antrea Kyriakidou

Business Development Manager

Martin Bakker

Business Development Advisor

More stability. More impact.

Our mission is to unlock the full potential of therapeutic proteins, not by redesigning them, but by reinforcing what already works. We use INCYPRO to extend half-life, enhance stability, and bring clarity to performance. Beyond therapeutics, we work with partners to apply this stability across research tools and industrial enzymes, wherever precision matters.

Contact us to learn more about our work or explore collaboration opportunities